On Friday, Cognition Therapeutics Inc (CGTX) stock saw a modest uptick, ending the day at $0.63 which represents no change from the prior close of of $0.63. The stock opened at $0.64 and touched a low ...
"Biological ensembles use collective intelligence to tackle challenges together, but suboptimal coordination can undermine the effectiveness of group cognition," the team wrote in their paper, ...
Researchers at the California Institute of Technology have unveiled a startling revelation about the human mind: our thoughts ...
Language and social cognition are fundamental to human communication. But how do these capacities interact? In a review paper ...
Cognition Therapeutics (CGTX) announced topline results from the exploratory Phase 2 ‘SHIMMER’ study demonstrating CT1812 ...
Medical Xpress on MSN7d
New study reveals how brain stimulation improves cognition, decision-making in mental health disordersthe research team developed a preclinical model of human brain stimulation therapy and found that this therapy works by ...
This second route to joy is demonstrated in the prayer of another Old Testament prophet, Habakkuk. In response to his ...
AI isn't just changing how we think—it's dissolving the boundaries between human and machine cognition in unexpected ways.
Writing skills are going to become very critical because people are going to be able to tell the difference between AI ...
Cognition Therapeutics' CT1812 improves dementia with Lewy bodies outcomes, reducing anxiety, hallucinations, and functional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback